#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11844	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2196	534.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1452	1452	C	637	C,A	622,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11844	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2196	534.8	0	HET	.	.	.	C207T,A	.	207	207	C	475	475	C	665	C,T,A	521,113,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22490	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3421	653.0	0	.	n	.	0	T695C	SNP	695	695	T	971	971	C	722	C,T	696,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22490	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3421	653.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2247	2247	C	682	C	658	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22490	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3421	653.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2321	2321	A	676	A	667	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22490	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3421	653.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2873	2873	C	626	C	608	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22490	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3421	653.0	0	HET	.	.	.	A1638G	.	1638	1638	A	1914	1914	A	749	A,G	570,164	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22490	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3421	653.0	0	HET	.	.	.	C1811T,G	.	1811	1811	C	2087	2087	C	720	C,T,G	525,172,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1546	folP	855	855	100.0	folP.l15.c17.ctg.1	1526	100.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1009	1011	AGC	153;154;155	A;G;C	150;150;147	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4960	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	147.9	1	SNP	p	S91F	1	.	.	271	273	TTC	596	598	TTC	200;199;199	T;T;C	195;194;190	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4960	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	147.9	1	SNP	p	D95G	1	.	.	283	285	GGC	608	610	GGC	186;184;185	G;G;C	176;171;176	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4960	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	147.9	1	SNP	p	G95N	0	.	.	283	285	GGC	608	610	GGC	186;184;185	G;G;C	176;171;176	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1452	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1236	116.7	1	SNP	p	G45D	0	.	.	133	135	GGC	414	416	GGC	205;204;206	G;G;C	202;198;203	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	730	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1011	71.9	0	.	n	.	0	A197.	DEL	197	197	A	577	577	A	190	A	188	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	140.5	1	SNP	p	D86N	0	.	.	256	258	GAC	511	513	GAC	164;163;163	G;A;C	159;154;160	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	140.5	1	SNP	p	S87R	1	.	.	259	261	CGT	514	516	CGT	165;163;163	C;G;T	162;157;155	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	140.5	1	SNP	p	R87W	0	.	.	259	261	CGT	514	516	CGT	165;163;163	C;G;T	162;157;155	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	140.5	1	SNP	p	R87I	0	.	.	259	261	CGT	514	516	CGT	165;163;163	C;G;T	162;157;155	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	140.5	1	SNP	p	S88P	0	.	.	262	264	TCC	517	519	TCC	164;164;163	T;C;C	160;159;160	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3386	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2758	122.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1634	1636	GGC	175;175;174	G;G;C	169;169;170	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3296	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2307	141.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1231	1233	GCC	185;187;187	G;C;C	179;184;183	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3296	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2307	141.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1234	1236	ATG	187;186;185	A;T;G	182;179;178	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3296	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2307	141.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1246	1248	ACC	191;191;196	A;C;C	181;186;186	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3296	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2307	141.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1246	1248	ACC	191;191;196	A;C;C	181;186;186	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3296	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2307	141.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1747	1749	ACC	184;184;185	A;C;C	174;174;177	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3296	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2307	141.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1801	1803	GCG	178;179;181	G;C;G	168;173;174	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3296	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2307	141.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1801	1803	GCG	178;179;181	G;C;G	168;173;174	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3296	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2307	141.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1924	1926	GGT	145;146;142	G;G;T	143;142;138	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3296	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2307	141.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1933	1935	AGC	130;130;130	A;G;C	127;126;127	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3296	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2307	141.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1951	1953	CCG	117;117;114	C,G;C;G	105,3;104;100	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4810	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3093	154.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1657	1659	CCG	163;162;162	C;C;G,T,C	151;156;149,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2192	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1822	119.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	654	654	C	169	C	159	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2344	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1715	135.8	0	.	p	.	0	E209K	NONSYN	625	627	GAA	992	994	AAA	192;193;198	A;A;A	186;187;192	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2344	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1715	135.8	0	.	p	.	0	G210E	NONSYN	628	630	GGA	995	997	GAA	198;199;199	G;A;A	186;190;192	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2344	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1715	135.8	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1121	1123	GAA	149;151;152	G;A;A	146;149;149	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2344	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1715	135.8	1	SNP	p	G120K	1	.	.	358	360	AAG	725	727	AAG	195;195;191	A;A;G	186;190;176	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2344	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1715	135.8	1	SNP	p	N121D	0	.	.	361	363	AAC	728	730	AAC	191;191;191	A;A;C	183;184;184	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2344	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1715	135.8	1	SNP	p	A121N	1	.	.	361	363	AAC	728	730	AAC	191;191;191	A;A;C	183;184;184	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8232	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4782	171.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	998	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1190	83.8	1	SNP	p	V57M	1	.	.	169	171	ATG	643	645	ATG	177;179;179	A;T;G	177;176;176	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
